These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28429537)

  • 1. Preliminary findings on the safety of 1.5 and 3 Tesla magnetic resonance imaging in cardiac pacemaker patients.
    van Dijk VF; Delnoy PPHM; Smit JJJ; Ramdat Misier RA; Elvan A; van Es HW; Rensing BJWM; Raciti G; Boersma LVA
    J Cardiovasc Electrophysiol; 2017 Jul; 28(7):806-810. PubMed ID: 28429537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical safety of an MRI conditional implantable cardioverter defibrillator system: A prospective Monocenter ICD-Magnetic resonance Imaging feasibility study (MIMI).
    Kypta A; Blessberger H; Hoenig S; Saleh K; Lambert T; Kammler J; Fellner F; Lichtenauer M; Steinwender C
    J Magn Reson Imaging; 2016 Mar; 43(3):574-84. PubMed ID: 26335332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical safety of the ProMRI pacemaker system in patients subjected to head and lower lumbar 1.5-T magnetic resonance imaging scanning conditions.
    Bailey WM; Rosenthal L; Fananapazir L; Gleva M; Mazur A; Rinaldi CA; Kypta A; Merkely B; Woodard PK;
    Heart Rhythm; 2015 Jun; 12(6):1183-91. PubMed ID: 25680307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical safety of the ProMRI pacemaker system in patients subjected to thoracic spine and cardiac 1.5-T magnetic resonance imaging scanning conditions.
    Bailey WM; Mazur A; McCotter C; Woodard PK; Rosenthal L; Johnson W; Mela T;
    Heart Rhythm; 2016 Feb; 13(2):464-71. PubMed ID: 26409098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical safety of the Iforia implantable cardioverter-defibrillator system in patients subjected to thoracic spine and cardiac 1.5-T magnetic resonance imaging scanning conditions.
    Awad K; Griffin J; Crawford TC; Lane Cox S; Ferrick K; Mazur A; Pena RE; Lloyd SG; Michalski J; Johnson W; Bailey WM
    Heart Rhythm; 2015 Oct; 12(10):2155-61. PubMed ID: 26049048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical safety and performance of a MRI conditional pacing system in patients undergoing cardiac MRI.
    Ching CK; Chakraborty RN; Kler TS; Pumprueg S; Ngarmukos T; Chan JYS; Anand S; Yadav R; Sitthisook S; Yim KW; Jaswal RK; Bhargava K
    Pacing Clin Electrophysiol; 2017 Dec; 40(12):1389-1395. PubMed ID: 29090491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategy for safe performance of extrathoracic magnetic resonance imaging at 1.5 tesla in the presence of cardiac pacemakers in non-pacemaker-dependent patients: a prospective study with 115 examinations.
    Sommer T; Naehle CP; Yang A; Zeijlemaker V; Hackenbroch M; Schmiedel A; Meyer C; Strach K; Skowasch D; Vahlhaus C; Litt H; Schild H
    Circulation; 2006 Sep; 114(12):1285-92. PubMed ID: 16966587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determining the risks of magnetic resonance imaging at 1.5 tesla for patients with pacemakers and implantable cardioverter defibrillators.
    Cohen JD; Costa HS; Russo RJ
    Am J Cardiol; 2012 Dec; 110(11):1631-6. PubMed ID: 22921995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter study of the safety and effects of magnetic resonance imaging in patients with coronary sinus left ventricular pacing leads.
    Sheldon SH; Bunch TJ; Cogert GA; Acker NG; Dalzell CM; Higgins JV; Espinosa RE; Asirvatham SJ; Cha YM; Felmlee JP; Watson RE; Anderson JL; Brooks MH; Osborn JS; Friedman PA
    Heart Rhythm; 2015 Feb; 12(2):345-9. PubMed ID: 25433144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial of pacemaker and lead system for safe scanning at 1.5 Tesla.
    Gimbel JR; Bello D; Schmitt M; Merkely B; Schwitter J; Hayes DL; Sommer T; Schloss EJ; Chang Y; Willey S; Kanal E;
    Heart Rhythm; 2013 May; 10(5):685-91. PubMed ID: 23333721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deactivation vs. asynchronous pacing - prospective evaluation of a protocol for rhythm management in patients with magnetic resonance conditional pacemakers undergoing adenosine stress cardiovascular magnetic resonance imaging.
    Klein-Wiele O; Garmer M; Barbone G; Urbien R; Busch M; Kara K; Schäfer H; Schulte-Hermes M; Hailer B; Grönemeyer D
    BMC Cardiovasc Disord; 2017 Jun; 17(1):142. PubMed ID: 28577544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immediate and 12 months follow up of function and lead integrity after cranial MRI in 356 patients with conventional cardiac pacemakers.
    Muehling OM; Wakili R; Greif M; von Ziegler F; Morhard D; Brueckmann H; Becker A
    J Cardiovasc Magn Reson; 2014 Jun; 16(1):39. PubMed ID: 24903354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monocenter Investigation Micra® MRI study (MIMICRY): feasibility study of the magnetic resonance imaging compatibility of a leadless pacemaker system.
    Blessberger H; Kiblboeck D; Reiter C; Lambert T; Kellermair J; Schmit P; Fellner F; Lichtenauer M; Kypta A; Steinwender C; Kammler J
    Europace; 2019 Jan; 21(1):137-141. PubMed ID: 29986008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of Magnetic Resonance Imaging in Patients with Cardiac Devices.
    Nazarian S; Hansford R; Rahsepar AA; Weltin V; McVeigh D; Gucuk Ipek E; Kwan A; Berger RD; Calkins H; Lardo AC; Kraut MA; Kamel IR; Zimmerman SL; Halperin HR
    N Engl J Med; 2017 Dec; 377(26):2555-2564. PubMed ID: 29281579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-World Evaluation of Magnetic Resonance Imaging in Patients With a Magnetic Resonance Imaging Conditional Pacemaker System: Results of 4-Year Prospective Follow-Up in 2,629 Patients.
    Williamson BD; Gohn DC; Ramza BM; Singh B; Zhong Y; Li S; Shanahan L;
    JACC Clin Electrophysiol; 2017 Nov; 3(11):1231-1239. PubMed ID: 29759618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monocenter feasibility study of the MRI compatibility of the Evia pacemaker in combination with Safio S pacemaker lead.
    Wollmann CG; Steiner E; Vock P; Ndikung B; Mayr H
    J Cardiovasc Magn Reson; 2012 Sep; 14(1):67. PubMed ID: 23009683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artefacts in 1.5 Tesla and 3 Tesla cardiovascular magnetic resonance imaging in patients with leadless cardiac pacemakers.
    Kiblboeck D; Reiter C; Kammler J; Schmit P; Blessberger H; Kellermair J; Fellner F; Steinwender C
    J Cardiovasc Magn Reson; 2018 Jul; 20(1):47. PubMed ID: 29973228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safe magnetic resonance imaging scanning of patients with cardiac rhythm devices: a role for computer modeling.
    Wilkoff BL; Albert T; Lazebnik M; Park SM; Edmonson J; Herberg B; Golnitz J; Wixon S; Peltier J; Yoon H; Willey S; Safriel Y
    Heart Rhythm; 2013 Dec; 10(12):1815-21. PubMed ID: 24096164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early performance of a miniaturized leadless cardiac pacemaker: the Micra Transcatheter Pacing Study.
    Ritter P; Duray GZ; Steinwender C; Soejima K; Omar R; Mont L; Boersma LV; Knops RE; Chinitz L; Zhang S; Narasimhan C; Hummel J; Lloyd M; Simmers TA; Voigt A; Laager V; Stromberg K; Bonner MD; Sheldon TJ; Reynolds D;
    Eur Heart J; 2015 Oct; 36(37):2510-9. PubMed ID: 26045305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective evaluation of a protocol for magnetic resonance imaging of patients with implanted cardiac devices.
    Nazarian S; Hansford R; Roguin A; Goldsher D; Zviman MM; Lardo AC; Caffo BS; Frick KD; Kraut MA; Kamel IR; Calkins H; Berger RD; Bluemke DA; Halperin HR
    Ann Intern Med; 2011 Oct; 155(7):415-24. PubMed ID: 21969340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.